Rebecca C. Coll

Rebecca C. Coll

Auto-generated profile, based on publicly available information

Rebecca C. Coll

Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2015 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RCRebecca C Coll
Rebecca C Coll
ARAvril Robertson
Avril Robertson
JCJae Jin Chae
Jae Jin Chae
SHSarah C Higgins
Sarah C Higgins
RMRaúl Muñoz-Planillo
Raúl Muñoz-Planillo
Luke O'NeillLuke O'Neill
Luke O'Neill

12 September 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SMSeth L Masters
Seth L Masters
ADAisling Dunne
Aisling Dunne
SSShoba L Subramanian
Shoba L Subramanian
RHRebecca L Hull
Rebecca L Hull
GTGillian M Tannahill
Gillian M Tannahill
Luke O'NeillLuke O'Neill
Luke O'Neill

13 May 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
RCRebecca C. Coll
Rebecca C. Coll
JHJames R. Hill
James R. Hill
CDChristopher J. Day
Christopher J. Day
AZAlina Zamoshnikova
Alina Zamoshnikova
DBDave Boucher
Dave Boucher
KSKate Schroder
Kate Schroder

3 May 2022 in Trends in Pharmacological Sciences
Verified
Journal Article
Open access
RCRebecca C. Coll
Rebecca C. Coll
KSKate Schroder
Kate Schroder
PPPablo Pelegrín
Pablo Pelegrín
The nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome has emerged as a key mediator of pathological inflammation in many diseases and is an exciting drug target. Here, we review the molecular basis of NLRP3 inhibition by drug-like small molecules under development as novel therapeutics. We also summarize recent strategies to block pyroptosis as a novel approach to suppress chronic inflammation. Major recent developments in this area include the elucidation of mechanisms of action (MoAs) by which small molecules block NLRP3 inflammasome assembly and gasdermin D (GSDMD)-induced pyroptosis. We also discuss the status of clinical trials using agents that block specific components of the NLRP3 pathway, including their potential clinical applications for the treatment of many diseases.

6 February 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DBDave Boucher
Dave Boucher
MMMercedes Monteleone
Mercedes Monteleone
RCRebecca C. Coll
Rebecca C. Coll
KCKaiwen W. Chen
Kaiwen W. Chen
CRConnie M. Ross
Connie M. Ross
KSKate Schroder
Kate Schroder
Host-protective caspase-1 activity must be tightly regulated to prevent pathology, but mechanisms controlling the duration of cellular caspase-1 activity are unknown. Caspase-1 is activated on inflammasomes, signaling platforms that facilitate caspase-1 dimerization and autoprocessing. Previous studies with recombinant protein identified a caspase-1 tetramer composed of two p20 and two p10 subunits (p20/p10) as an active species. In this study, we report that in the cell, the dominant species of active caspase-1 dimers elicited by inflammasomes are in fact full-length p46 and a transient species, p33/p10. Further p33/p10 autoprocessing occurs with kinetics specified by inflammasome size and cell type, and this releases p20/p10 from the inflammasome, whereupon the tetramer becomes unstable in cells and protease activity is terminated. The inflammasome–caspase-1 complex thus functions as a holoenzyme that directs the location of caspase-1 activity but also incorporates an intrinsic self-limiting mechanism that ensures timely caspase-1 deactivation. This intrinsic mechanism of inflammasome signal shutdown offers a molecular basis for the transient nature, and coordinated timing, of inflammasome-dependent inflammatory responses.

17 June 2016 in Science
Verified
Journal Article
Closed access
PDF file
GAGiuseppina Arbore
Giuseppina Arbore
EWErin E. West
Erin E. West
RSRosanne Spolski
Rosanne Spolski
ARAvril Robertson
Avril Robertson
AKAndreas Klos
Andreas Klos
CKClaudia Kemper
Claudia Kemper
Innate immune crosstalk in T cells: The classical view of immune activation is that innate immune cells, such as macrophages and dendritic cells, recognize invading microbes and then alert adaptive immune cells, such as T cells, to respond. Arbore et al. now show that innate and adaptive immunity converge in human and mouse T cells. Activated T cells express components of the complement cascade, which in turn leads to the assembly of NLRP3 inflammasomes—both critical components of innate immunity that help hosts detect and eliminate microbes. In T cells, complement and inflammasomes work together to push T cells to differentiate into a specialized subset of T cells important for eliminating intracellular bacteria. Science , this issue p. 10.1126/science.aad1210